Scientific Articles about Cervical Cancer

Return to index

This page contains a list of citations for selected publications authored by CDC's Division of Cancer Prevention and Control (DCPC) staff members. Fiscal years begin October 1 and end September 30; for example, fiscal year 2006 began October 1, 2005 and ended September 30, 2006.

Fiscal Year 2009

Castrucci BC, Echegollen Guzmán A, Saraiya M, Smith BR, Lewis KL, Coughlin SS, Gossman GL, McDonald JA, Foulkes H, Mirchandani G, Correa-Nieto Canedo L, Garcia IM, Acuña J. Cervical cancer screening among women who gave birth in the US-Mexico border region, 2005: the Brownsville-Matamoros Sister City Project for Women's Health. Preventing Chronic Disease 2008;5(4):A116.

Fiscal Year 2008

Balamurugan A, Ahmed F, Saraiya M Kosary C, Schwenn M, Cokkinides V, Flowers LC, Pollack LA. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors. Cancer 2008;113(S10):2919–2925.

Baron RC, Rimer BK, Breslow RA, Coates RJ, Kerner J, Melillo S, Habarta N, Kalra GP, Chattopadhyay S, Wilson KM, Lee NC, Mullen PD, Coughlin SS, Briss PA; Task Force on Community Preventive Services. Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening: a systematic review. American Journal of Preventive Medicine 2008;35(1 Suppl):S34–55.

Baron RC, Rimer BK, Coates RJ, Kerner J, Kalra GP, Melillo S, Habarta N, Wilson KM, Chattopadhyay S, Leeks K, Task Force on Community Preventive Services. Client-directed interventions to increase community access to breast, cervical, and colorectal cancer screening: A systematic review. American Journal of Preventive Medicine 2008;35(1 Suppl):S56–66.

Baron RC, Rimer BK, Coates RJ, Kerner J, Mullen PD, Chattopadhyay S, Briss PA; Task Force on Community Preventive Services. Methods for conducting systematic reviews of evidence on effectiveness and economic efficiency of interventions to increase screening for breast, cervical, and colorectal cancers. American Journal of Preventive Medicine 2008;35(1 Suppl):S26–33.

Bates JH, Parikh-Patel A, Hofer BM. Cervical cancer incidence, mortality, and survival among Asian subgroups in California, 1990–2004. Cancer 2008;113(S10):2955–2963.

Becker TM, Espey DK, Lawson HW, Saraiya M, Jim MA, Waxman AG. Regional differences in cervical cancer incidence among American Indians and Alaska Natives, 1999–2004. Cancer 2008;113(S5):1234–1243.

Breslow RA, Rimer BK, Baron RC, Coates RJ, Kerner J, Wilson KM, Lee NC, Mullen PD, Coughlin SS, Briss PA. Introducing the Community Guide's reviews of evidence on interventions to increase screening for breast, cervical, and colorectal cancers. American Journal of Preventive Medicine 2008;35(1 Suppl):S14–20.

Castle P, Solomon D, Saslow D, Schiffman M. Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United States. Cancer 2008;113(S10):3031–3035.

Chesson HW, Ekwueme DU, Saraiya M, Markowitz LE. Cost-effectiveness of human papillomavirus vaccination in the United States. Emerging Infectious Diseases 2008;14(2):244–251.

Copeland G, Datta SD, Spivak G, Garvin AD, Cote M. Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985–2003. Cancer 2008;113(S10):2946–2954.

Coughlin SS, Leadbetter S, Richards T, Sabatino SA. Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002. Social Science and Medicine 2008;66(2):260–275.

Coughlin SS, Richards TB, Nasseri K, Weiss NS, Wiggins C, Saraiya M, Stinchcomb DG, Vensor V, Nielson C. Cervical cancer incidence in the United States in the US-Mexico border region, 1998–2003. Cancer 2008;113(S10):2964–2973.

Ekwueme DU, Gardner JG, Subramanian S, Tangka FK, Bapat B, Richardson LC. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004. Cancer 2008;112(3):626–635.

Hopenhayn C, King JB, Christian A, Huang B, Christian WJ. Variability of cervical cancer rates across 5 Appalachian states, 1998–2003. Cancer 2008;113(S10):2974–2980.

Kagawa-Singer M, Pourat N, Breen N, Coughlin S, McLean TA, McNeel TS, Ponce NA. Breast and cervical cancer screening rates of subgroups of Asian American women in California. Medical Care Research and Review 2007;64(6):706–730.

Pagliusi S, Lawson H, Singer A, Monsonego J. EUROGIN 2007 Patient Education Conference: Sharing experiences and action in cervical cancer prevention—an overview. Part 2. Vaccine 2008;26(Suppl 1):A33–A36.

Sabatino SA, Habarta N, Baron RC, Coates RJ, Rimer BK, Kerner J, Coughlin SS, Kalra GP, Chattopadhyay S; Task Force on Community Preventive Services. Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers: Systematic reviews of provider assessment and feedback and provider incentives. American Journal of Preventive Medicine 2008;35(1 Suppl):S67–74.

Saraiya M, Ahmed F, White MC, Lawson H, Unger ER, Eheman CR. Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US. Cancer 2008;113(S10):2837–2840.

Steele CB, Thomas CN, Richardson LC. Human papillomavirus-related content in state and tribal comprehensive cancer control plans. Journal of Women's Health 2008;17(1):5–10.

Tiro JA, Saraiya M, Jain N, Liddon N, Cokkinides V, Lai SM, Breen N, Wideroff L. Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer 2008;113(S10):3013–3030.

Tsui J, Saraiya M, Thompson T, Dey A, Richardson L. Cervical cancer screening among foreign-born women by birthplace and duration in the United States. Journal of Women's Health 2007;16(10):1447–1457.

Watson M, Saraiya M, Benard V, Coughlin SS, Flowers LC, Cokkinides V, Schwenn M, Huang Y, Giuliano AR. Burden of cervical cancer in the United States, 1998–2003. Cancer 2008;113(S10):2855–2864.

Fiscal Year 2007

Benard VB, Coughlin SS, Thompson T, Richardson LC. Cervical cancer incidence in the United States by area of residence, 1998–2001. Obstetrics and Gynecology 2007;110(3):681–686.

Byrd TL, Chavez R, Wilson KM. Barriers and facilitators of cervical cancer screening among Hispanic women. Ethnicity and Disease 2007;17(1):129–134.

Coughlin SS, King J, Richards TB, Ekwueme DU. Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiology, Biomarkers and Prevention 2006;15(11):2154–2159.

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports 2007;56(RR-2):1–24.

Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW. Cervical cancer incidence in a prevaccine era in the United States, 1998–2002. Obstetrics and Gynecology 2007;109(2):360–370.

Saraiya M, Irwin KL, Carlin L, Chen X, Jain N, Benard V, Montano DE. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Cancer 2007;110(5);1024–1032.

Fiscal Year 2006

Calloway C, Jorgensen CM, Saraiya M, Tsui J. A content analysis of news coverage of the HPV vaccine by U.S. newspapers, January 2002–June 2005. Journal of Women's Health 2006;15(7):803–809.

Cooper CP, Saraiya M, McLean TA, Hannan J, Liesmann JM, Rose SW, Lawson HW. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program. Journal of Women's Health 2005;14(8):670–678.

Kulasingam SL, Myers ER, Lawson HW, McConnell KJ, Kerlikowske K, Melnikow J, Washington AE, Sawaya GF. Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal Pap tests. Obstetrics and Gynecology 2006;107(2 Pt 1):321–328.

Lawson, HW. Chapter 11. Cervical Cancer Screening. In: Clinical Gynecology. Bieber EJ, Sanfilippo JS, Horowitz IR, eds. Philadelphia: Churchill Livingstone, 2006.

Richardson LC, Benard VB. Can high-grade cervical lesions be managed in a single clinic visit? Nature Clinical Practice Oncology 2006;3(8):420–421.

Sherris J, Friedman A, Wittet S, Davies P, Steben M, Saraiya M. Chapter 25: Education, training, and communication for HPV vaccines. Vaccine 2006;24(Suppl 3):S210–218.

Wilson KM, Orians CE. Considerations in recruiting underscreened women to focus groups on screening for cervical cancer. Health Promotion Practice 2005;6(4):379–384.

Fiscal Year 2005

Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W. Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstetrics and Gynecology 2005;105(6):1323–1328.

Chattopadhyay SK, Ebrahim SH, Tao G, McKenna MT. Use of cervical cancer screening among insured women: The extent of missed opportunities. Health Policy 2005;73(2):194–201.

Coughlin SS, Breslau E, Thompson T, Benard V. Physician recommendation for Papanicolaou testing among United States women, 2000.* Cancer Epidemiology, Biomarkers and Prevention 2005;14(5):1143–1148.

Leman R, Espey D, Cobb N. Invasive cervical cancer among American Indian women in the northern plains, 1994–1998: Incidence, mortality, and missed opportunities. Public Health Report 2005;120(3):283–287.

Saraiya M, Sawaya GF. Cervical cancer screening among women without a cervix. Journal of the American Medical Association 2004;292(13):1551–1552.

Fiscal Year 2004

Benard VB, Eheman CR, Lawson HW, Blackman DK, Anderson C, Helsel W, Thames SF, Lee NC. Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995–2001.* Obstetrics and Gynecology 2004;103(3):564–571.

Berg GD, Chattopadhyay SK. Determinants of hospital length of stay for cervical dysplasia and cervical cancer: Does managed care matter? The American Journal of Managed Care 2004;10(1):33–38.

Coughlin SS, Uhler RJ, Hall HI, Briss PA. Nonadherence to breast and cervical cancer screening: What are the linkages to chronic disease risk? Preventing Chronic Disease 2004;1(1):1–20.

French C, True S, McIntyre R, Sciulli M, Maloy K. State implementation of the Breast and Cervical Cancer Prevention and Treatment Act of 2000: A collaborative effort among government agencies. Public Health Reports 2004;119(3):279–285.

Hall HI, Jamison PM, Coughlin SS. Breast and cervical cancer mortality in the Mississippi Delta, 1979–1998. Southern Medical Journal 2004;97(3):264–272.

Hall HI, Jamison PM, Coughlin SS, Uhler RJ. Breast and cervical cancer screening among Mississippi Delta women. Journal of Health Care for the Poor and Underserved 2004;15(3):375–389.

Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER, Washington AE. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. New England Journal of Medicine 2003;349(16):1501–1509.

Sawaya G, Kulasingam S, Lawson H. Risk of cervical cancer associated with extending screening intervals in well-screened women—letter response. New England Journal of Medicine 2004;330:414–415.

Wingo PA, Cardinez C, Landis SH, Greenlee R, Anderson RN, Ries LAG, Thun MJ. Long-term trends in cancer mortality in the United States, 1930–1998. Cancer 2003;97(12 Suppl):3133–3275.

Fiscal Year 2003

Coughlin SS, Thompson TD, Seeff L, Richards T, Stallings F. Breast, cervical, and colorectal carcinoma screening in a demographically defined region of the southern United States. Cancer 2002;95(10):2211–2227.

Coughlin SS, Uhler RJ, Richards T, Wilson K. Breast and cervical cancer screening practices among Hispanic and non-Hispanic women residing near the United States-Mexico border, 1999–2000. Family and Community Medicine 2003;26(2):130–139.

Hall HI, Armstrong LR, Wingo PA, Kassim S. Centers for Disease Control and Prevention. Invasive cervical cancer among Hispanic and non-Hispanic women—United States, 1992–1999. MMWR 2002;51(47):1067–1070.

Seeff LC, McKenna MT. Cervical cancer mortality among foreign-born women living in the United States, 1985 to 1996. Cancer Detection and Prevention 2003;27(3):203–208.

Fiscal Year 2002

Coughlin SS, Caplan LS, Lawson HW. Cervical cancer screening in the workplace: Research, review and evaluation. Journal of Occupational Health Nursing 2002;50(1):32–39.

Coughlin SS, Thompson TD, Hall HI, Logan P, Uhler RJ. Breast and cervical cancer carcinoma screening among women in rural and non-rural areas of the United States, 1998–1999. Cancer 2002;94(11):2801–2812.

Coughlin SS, Uhler RJ. Breast and cervical cancer screening among Hispanic women in the United States and Puerto Rico, 1998–1999. Preventive Medicine 2002;34(2):242–251.

Coughlin SS, Wilson KM. Breast and cervical cancer screening among migrant and seasonal farm workers: A review. Cancer Detection and Prevention 2002;26(3):203–209.

Hall HI, Uhler RJ, Coughlin SS, Miller DS. Breast and cervical cancer screening among Appalachian women.* Cancer Epidemiology, Biomarkers and Prevention 2002;11(1):137–142.

Resha K. NBCCEDP: Improves access to lifesaving cancer screening services. Hematology Oncology News and Issues 2002;1:27–29.

Saraiya M, Lee NC, Blackman D, Smith MJ, McKenna M. Observations from the CDC: An assessment of Pap smears and hysterectomies among women in the United States. Journal of Women's Health and Gender-Based Medicine 2002;11(2):103–109.

Fiscal Year 2001

Benard VB, Lee NC, Piper M, Richardson L. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991–1998 (United States). Cancer Causes and Control 2001;12(1):61–68.

Coughlin SS, Caplan LS, Lawson HW. Cervical cancer screening in the workplace. Research review and evaluation. Journal of American Association of Occupational Health Nurses 2002;50(1):32–39.

Saraiya M, Lee NC, Blackman D, Smith MJ, McKenna M. Self-reported Papanicolaou smears and hysterectomies among women in the United States.* Obstetrics and Gynecology 2001;98(2):269–78.

Sawaya G, Kerlikowske K, Lee NC, Gildengorin G, Washington AE, Saraiya M. Incidence of Pap test abnormalities within 3 years of a normal Pap test—United States, 1991–1998. MMWR 2000;49(44):1001–1003.

Sawaya GF, Kerlikowske K, Lee NC, Gildengorin G, Washington AE. Reply to letter to the editor: Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstetrics and Gynecology 2000;96:1026.

Fiscal Year 2000

Coughlin SS, Uhler RJ. Breast and cervical cancer screening practices among Asian and Pacific Islander women in the United States, 1994–1997.* Cancer Epidemiology, Biomarkers and Prevention 2000;9(6):597–603.

Coughlin SS, Uhler RJ, Blackman DK. Breast and cervical cancer screening practices among American Indian and Alaska Native women in the United States, 1992–1997. [published erratum appears in Preventive Medicine 2000;30(4):348]. Preventive Medicine 1999;29:287–295.

Hall HI, Rogers JD, Weir HK, Miller DS, Uhler RH. Breast and cervical carcinoma mortality among women in the Appalachian region of the U.S., 1976–1996. Cancer 2000;89(7):1593–1602.

Lawson HW, Henson RM, Bobo JK, Kaeser MK. Implementing recommendations for the early detection of breast and cervical cancer among low-income women. MMWR 2000;49(RR–02):35–55.

Sawaya GF, Kerlikowske K, Lee NC, Gildengorin G, Washington AE. Frequency of cervical smear abnormalities within 3 years of normal cytology.* Obstetrics and Gynecology 2000;96(2):219–223.

*Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links.